Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

50%

2 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 2
1(25.0%)
N/A
1(25.0%)
Phase 4
1(25.0%)
Phase 3
1(25.0%)
4Total
Phase 2(1)
N/A(1)
Phase 4(1)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06966778Not ApplicableRecruiting

Oxybutynin ER to Promote Early Continence Recovery After Robotic Prostatectomy: A Randomized Controlled Trial

Role: collaborator

NCT06051786Phase 2Completed

A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Perennial Allergic Rhinitis

Role: lead

NCT05895877Phase 3Unknown

Evaluate the Efficacy and Safety of Goofice® (Elobixibat) in Patients With Chronic Constipation

Role: lead

NCT00190034Phase 4Suspended

Acetylcysteine Against Acute Renal Insult During Cardiopulmonary Bypass.

Role: collaborator

All 4 trials loaded